Suppression of aryl hydrocarbon hydroxylase activity in human primary lung carcinoma x mouse hepatoma somatic cell...

Area of Science:

• Cell Biology
• Biochemistry
• Toxicology

Background:

• Aryl hydrocarbon hydroxylase (AHH) is a key enzyme in metabolizing environmental pollutants.
• Cellular models are crucial for understanding enzyme induction and suppression mechanisms.
• Drug-resistant cell lines facilitate somatic cell hybridization studies.

Purpose of the Study:

• To investigate the expression of AHH induction in somatic cell hybrids.
• To determine if AHH inducibility is suppressed in hybrids of human and mouse cells.
• To characterize AHH activity and drug resistance in variant cell lines.

Main Methods:

• Isolation of variant mouse hepatoma cells inducible for AHH and deficient in hypoxanthine guanine phosphoribosyl-transferase.
• Isolation of variant human lung carcinoma cells noninducible for AHH and deficient in thymidine kinase.
• Somatic cell hybridization of these variant lines.
• Assay of AHH activity induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Main Results:

• Two somatic cell hybrids were generated from the variant human and mouse cell lines.
• AHH activity was not expressed in the studied hybrid cell lines.
• The results indicate suppression of AHH activity in the hybrid cells.

Conclusions:

• AHH activity is suppressed in somatic cell hybrids formed between AHH noninducible human lung carcinoma cells and AHH inducible mouse hepatoma cells.
• This suppression suggests a dominant inhibitory mechanism in the hybrid cells.
• Further research is needed to elucidate the molecular basis of AHH suppression.